Results 81 to 90 of about 21,294 (218)
First-in-human, open-label dose-escalation and dose-expansion study of the safety, pharmacokinetics, and antitumor effects of an oral ALK inhibitor ASP3026 in patients with advanced solid tumors [PDF]
Background ASP3026 is a second-generation anaplastic lymphoma kinase (ALK) inhibitor that has potent in vitro activity against crizotinib-resistant ALK-positive tumors.
Anthony Tolcher +8 more
core +3 more sources
Although crizotinib shows marked antitumor activity in anaplastic lymphoma kinase (ALK) rearrangement-positive non-small-cell lung cancer (NSCLC) patients, all treated patients ultimately develop resistance to this drug.
Sachi Okawa +12 more
doaj +1 more source
Lung cancer (LC) remains the leading cause of global cancer‐related death. Phytochemicals from medicinal plants are increasingly being considered as potential LC treatment agents due to their multi‐targeted action, safety, and accessibility. These have anticancer properties by regulating key molecular signaling pathways.
Md. Rezaul Islam +14 more
wiley +1 more source
Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones
ABSTRACT Mycosis fungoides (MF) is a unique type of lymphoma with an excellent prognosis presenting with a wide variety of clinical and histological findings. Recent sophisticated research techniques have revealed that very slow changes in the clinical and histological pictures of one patient over time are due to intratumoral heterogeneity.
Ryoma Honda +2 more
wiley +1 more source
A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. [PDF]
Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location.
Niibe, Yuzuru +4 more
core +3 more sources
Purpose With the continuous development and progress of next-generation gene sequencing technology, many types of anaplastic lymphoma kinase (ALK) rearrangement have been discovered.
Mingyue Wang +6 more
doaj +1 more source
ALK-Positive Squamous Cell Carcinoma Dramatically Responded to Alectinib
Anaplastic lymphoma kinase (ALK) rearrangement is usually observed in patients with adenocarcinoma. Herein, we report a case of squamous cell carcinoma (SCC) with ALK rearrangement treated with alectinib.
Ray Sagawa +3 more
doaj +1 more source
ALK-rearranged renal cell carcinomas in Polish population
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase, the activation of which is considered an important event in the pathogenesis of several neoplasms and a predictive factor for the targeted therapy with ALK inhibitors. Thus far, ALK rearrangements have been identified in 22 renal cell carcinomas in both pediatric and adult patients.
Adam, Gorczynski +6 more
openaire +4 more sources
Sequence of Immunological Events During IgE‐Mediated Allergic Reactions to Food
ABSTRACT Food allergies (FA) represent a significant global health burden. Upon allergen re‐exposure, allergic patients exhibit a sequence of symptoms that vary in terms of affected organ systems, severity, time of onset and allergen reactivity thresholds.
N. A. Nagy +7 more
wiley +1 more source
Nichtkleinzellige Lungenkarzinome: Subklassifikation und prädiktive molekulare Markeruntersuchungen in der Zytologie [PDF]
Zusammenfassung: In der Lungenkarzinomdiagnostik haben sich die Anforderungen an die Zytologie in den letzen Jahren deutlich verändert. Eine exakte Subtypisierung nichtkleinzelliger Lungenkarzinome (NSCLC) in Adeno- und Plattenepithelkarzinome ...
Bihl, M.P., Bubendorf, L., Savic, S.
core

